Back
38
Also listed as
SNNUF
OTC
Day Range
$32.12
$32.58
52-Week Range
$23.91
$38.79
Volume
407,315
50D / 200D Avg
$34.35
/
$33.93
Prev Close
$32.16
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.0 | 0.2 |
| P/B | 2.6 | 3.0 |
| ROE % | 11.9 | 3.6 |
| Net Margin % | 10.1 | 3.8 |
| Rev Growth 5Y % | 4.3 | 9.9 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
Hold
$37.50
+15.6%
Forward P/E
14.53
Forward EPS
$2.23
EPS Growth (est.)
+0.0%
Est. Revenue
6.59B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.16
$3.06 – $3.24
|
8.32B | 1 |
| FY2029 |
$2.95
$2.85 – $3.02
|
7.76B | 1 |
| FY2028 |
$2.75
$2.66 – $2.82
|
7.34B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-03 | $1.16 | $0.76 | -34.7% |
| 2025-08-05 | $0.86 | $0.67 | -21.7% |
| 2025-02-25 | $0.92 | $0.23 | -75.5% |
| 2024-10-31 | $0.79 | $0.25 | -68.8% |
| 2024-02-27 | $0.97 | $0.05 | -94.6% |
| 2023-08-03 | $0.73 | $0.10 | -86.5% |
| 2023-02-28 | $0.73 | $0.03 | -96.4% |
| 2022-07-02 | $0.76 | $0.10 | -86.7% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.53%
Growth (3Y)
0.77%
Growth (5Y)
0.19%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 27, 2026 | May 27, 2026 | $0.47 | 2.32% |
| Oct 03, 2025 | Nov 07, 2025 | $0.29 | 2.06% |
| Mar 28, 2025 | May 28, 2025 | $0.46 | 2.67% |
| Oct 04, 2024 | Nov 08, 2024 | $0.29 | 2.50% |
| Apr 01, 2024 | May 22, 2024 | $0.46 | 3.06% |
| Oct 05, 2023 | Nov 01, 2023 | $0.29 | 3.19% |
| Mar 30, 2023 | May 17, 2023 | $0.46 | 2.74% |
| Sep 29, 2022 | Oct 26, 2022 | $0.28 | 3.28% |
| Mar 31, 2022 | May 11, 2022 | $0.45 | 2.35% |
| Sep 30, 2021 | Oct 27, 2021 | $0.28 | 2.18% |
| Apr 05, 2021 | May 12, 2021 | $0.46 | 1.97% |
| Oct 01, 2020 | Oct 28, 2020 | $0.28 | 1.89% |
| Apr 02, 2020 | May 06, 2020 | $0.46 | 2.20% |
| Oct 03, 2019 | Oct 30, 2019 | $0.29 | 1.58% |
| Apr 04, 2019 | May 08, 2019 | $0.44 | 1.81% |
| Oct 04, 2018 | Oct 31, 2018 | $0.28 | 2.03% |
| Apr 05, 2018 | May 09, 2018 | $0.45 | 1.87% |
| Oct 05, 2017 | Nov 01, 2017 | $0.25 | 1.69% |
| Mar 29, 2017 | May 10, 2017 | $0.37 | 1.99% |
| Oct 05, 2016 | Oct 25, 2016 | $0.25 | 1.93% |
Key Takeaways
Revenue grew 4.34% annually over 5 years — modest growth
Earnings grew 52.05% over the past year
ROE of 11.87% — decent returns on equity
Generating 853.99M in free cash flow
PEG of 0.41 suggests growth is underpriced
Cash machine — converts 136.32% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.34%
Revenue (1Y)6.34%
Earnings (1Y)52.05%
FCF Growth (3Y)117.21%
Quality
Return on Equity
11.87%
ROIC8.75%
Net Margin10.14%
Op. Margin16.27%
Safety
Debt / Equity
0.63
Current Ratio2.57
Interest Coverage6.43
Valuation
P/E Ratio
22.02
Forward P/E14.53
P/B Ratio2.61
EV/EBITDA16.48
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.34% | Revenue Growth (3Y) | 5.52% |
| Earnings Growth (1Y) | 52.05% | Earnings Growth (3Y) | 54.34% |
| Revenue Growth (5Y) | 4.34% | Earnings Growth (5Y) | 4.57% |
| Profitability | |||
| Revenue (TTM) | 6.18B | Net Income (TTM) | 626.46M |
| ROE | 11.87% | ROA | 5.99% |
| Gross Margin | 68.01% | Operating Margin | 16.27% |
| Net Margin | 10.14% | Free Cash Flow (TTM) | 853.99M |
| ROIC | 8.75% | FCF Growth (3Y) | 117.21% |
| Safety | |||
| Debt / Equity | 0.63 | Current Ratio | 2.57 |
| Interest Coverage | 6.43 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.53% |
| Dividend Growth (3Y) | 0.77% | Dividend Growth (5Y) | 0.19% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 22.02 | Forward P/E | 14.53 |
| P/B Ratio | 2.61 | P/S Ratio | 2.23 |
| PEG Ratio | 0.41 | Forward PEG | N/A |
| EV/EBITDA | 16.48 | Fwd EV/EBITDA | 12.01 |
| Forward P/S | 2.09 | Fwd Earnings Yield | 6.88% |
| FCF Yield | 6.19% | ||
| Market Cap | 13.80B | Enterprise Value | 16.57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.18B | 5.81B | 5.55B | 5.22B | 5.21B |
| Net Income | 626.46M | 412.00M | 263.00M | 223.00M | 524.00M |
| EPS (Diluted) | 1.44 | 0.94 | 1.20 | 0.50 | 1.20 |
| Gross Profit | 4.20B | 4.05B | 3.82B | 3.68B | 3.67B |
| Operating Income | 1.01B | 657.00M | 425.00M | 315.00M | 593.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10.46B | 10.35B | 9.99B | 9.97B | 10.92B |
| Total Liabilities | 5.17B | 5.09B | 4.77B | 4.71B | 5.35B |
| Shareholders' Equity | 5.29B | 5.27B | 5.22B | 5.26B | 5.57B |
| Total Debt | 3.33B | 3.32B | 3.08B | 2.87B | 3.34B |
| Cash & Equivalents | 557.00M | 619.00M | 302.00M | 350.00M | 1.29B |
| Current Assets | 4.10B | 4.42B | 4.03B | 3.86B | 4.42B |
| Current Liabilities | 1.60B | 1.53B | 2.27B | 1.72B | 2.13B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#661 of 1049
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026